[Edaily Reporter KIM EUNG-TAE ] Global beauty company APR(278470)announced on the 30th that it had donated in-kind goods worth 2.4 billion won through the Community Chest of Korea. An interior view of APR’s office. (Photo courtesy of APR) This donation was planned to help improve the living conditions of vulnerable groups both domestically and internationally and to provide practical welfare support. The donated goods will be distributed primarily to social welfare facilities for women and comprehensive welfare centers in Korea, as well as to appropriate institutions in regions overseas that require support. In Korea, priority will be given to single-parent and unwed mother households. The donated goods included the company’s own clothing products suitable for everyday use and were selected based on the specific support needs and characteristics of the recipients in each region and institution. APR has been carrying out corporate social responsibility (CSR) activities since 2016 to support marginalized groups and disaster victims. The company has expanded its areas of support—including helping single-parent families become self-reliant, covering medical expenses for vulnerable children, and donating funds for disaster recovery—and practices giving in ways tailored to the recipients and circumstances, such as both cash and in-kind donations. Including this donation, APR’s cumulative social contribution has exceeded 13 billion won. Last year’s social contribution donations totaled 5.7 billion won, a 30% increase from the previous year. An APR official stated, “We find it deeply meaningful to be able to provide tangible support to neighbors in need, both domestically and internationally, through this donation,” adding, “We will continue to faithfully fulfill our corporate social responsibility through various social contribution activities and sustain our efforts to share with those in need.”
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…